Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2001
05/08/2001US6228586 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
05/08/2001US6228585 Gene markers for chronic mucosal injury
05/08/2001US6228584 Nucleotide sequences for use in the detection of streptococcus
05/08/2001US6228583 Assays for compounds which extend life span
05/08/2001US6228582 Screening for brain disorders; isolate mammalian tissue sample, test sample for preferential polymorphism in nucleotide sequences
05/08/2001US6228581 Human intronic and polymorphic SR-BI nucleic acids and uses therefor
05/08/2001US6228580 Nucleic acid detection method using nucleotide probes enabling both specific capture and detection
05/08/2001US6228578 Non-radioactive hybridization assay and kit
05/08/2001US6228577 Method, reagent and kit for genotyping of human papillomavirus
05/08/2001US6228576 Detecting enzymes inhibitor of a preferential polymerase; incubate sample and inhibitor, detect polymerase activity
05/08/2001US6228575 Classification of exogenous nucleotide seqences; mixing oligonucleotide probes and sample, analyze hybridization pattern and classify nucleotide sequences in sample
05/08/2001US6228345 Detection of cancer cells, incubation of embryos and detecting migration of cancer cells between membranes
05/08/2001US6228326 Suitable for use with a biosensor; used as a secondary screen of compounds affecting the activity of integral membrane proteins
05/08/2001US6228128 Antimicrobial activity of laccases
05/08/2001US6228020 Compliant hearing aid
05/08/2001US6227658 Apparatus and method for forming thin film using ink-jet mechanism
05/08/2001CA2324484A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323464A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323191A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323183A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2196429C Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis
05/08/2001CA2097199C Preparation of prothrombin time reagents from recombinant human tissue factor and purified natural and synthetic phospholipids
05/08/2001CA2096010C Recombinant feline coronavirus s proteins
05/03/2001WO2001031580A2 Methods and devices for identifying patterns in biological systems
05/03/2001WO2001031566A2 Apparatus and methods for verifying the location of areas of interest within a sample in an imaging system
05/03/2001WO2001031344A2 Glycerol as a predictor of glucose tolerance
05/03/2001WO2001031343A2 Diagnosis and therapy of cancer using sgp28-related molecules
05/03/2001WO2001031342A2 DIAGNOSIS AND TREATMENT OF CANCER USING StAR POLYPEPTIDES AND POLYNUCLEOTIDES
05/03/2001WO2001031338A1 Fluorescent capture assay for kinase activity
05/03/2001WO2001031064A2 Relation of apolipoprotein e genotype and estrogen deprivation in alzheimer's disease
05/03/2001WO2001031063A1 Hybridization-triggered fluorescent detection of nucleic acids
05/03/2001WO2001031062A1 Assays for short sequence variants
05/03/2001WO2001031061A1 rpoB GENE FRAGMENTS AND A METHOD FOR THE DIAGNOSIS AND IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS AND NON-TUBERCULOSIS MYCOBACTERIAL STRAINS
05/03/2001WO2001031060A2 Identical-by-descent fragment enrichment
05/03/2001WO2001031059A2 Genetic biosensors using chemiluminescence
05/03/2001WO2001031058A2 Identification of cells for transplantation
05/03/2001WO2001031057A2 Double-strand nucleic acid probes and the use thereof
05/03/2001WO2001031056A2 Detection method by pcr
05/03/2001WO2001031055A2 Method and kit for the screening and/or the quantification of multiple homologous nucleic acid sequences on arrays
05/03/2001WO2001031054A1 Method of screening for inhibitors of asp1
05/03/2001WO2001031051A2 Antisense modulation of protein kinase c-theta expression
05/03/2001WO2001031039A1 Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination
05/03/2001WO2001031029A2 Human sphingosine kinase gene
05/03/2001WO2001031028A2 Mutant luciferase
05/03/2001WO2001031021A1 Multiple sclerosis-related superantigen
05/03/2001WO2001031017A2 Plants with a modified flower and seed development
05/03/2001WO2001031016A2 Processed human chemokines phc-1 and phc-2
05/03/2001WO2001031015A2 36p6d5: secreted tumor antigen
05/03/2001WO2001031011A2 Gene mining system and method
05/03/2001WO2001031008A2 Human and rat fgf-20 genes and gene expression products
05/03/2001WO2001031007A2 Nucleic acid molecules derived from rat brain and programmed cell death models
05/03/2001WO2001031006A2 Serum amyloid a isoform from colostrum
05/03/2001WO2001031005A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same
05/03/2001WO2001031003A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response
05/03/2001WO2001030993A1 Method of detecting target nucleic acid
05/03/2001WO2001030988A1 Methods for making and using fatty acid synthesis pathway reagents
05/03/2001WO2001030987A2 Tankyrase h, compositions involved in the cell cycle and methods of use
05/03/2001WO2001030986A2 Human pif1 dna helicase and uses thereof
05/03/2001WO2001030978A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
05/03/2001WO2001030973A2 Genetic sequences associated with neural cell proliferation and disease
05/03/2001WO2001030972A2 Regulation of gene expression by neuroleptic agents
05/03/2001WO2001030969A2 Stanniocalcin proteins and nucleic acids and methods based thereon
05/03/2001WO2001030967A2 Fluorescent cobalamins and uses thereof
05/03/2001WO2001030964A2 Anti-cancer nucleic acid and protein targets
05/03/2001WO2001030915A1 8-(anilino)-1-naphthalenesulfonate analogs and their use in analyte detection assays
05/03/2001WO2001030849A1 Dna molecules encoding l-glutamate-gated chloride channels from schistocerca americana
05/03/2001WO2001030848A2 Nucleic acids of the human abc1 gene and applications thereof
05/03/2001WO2001030845A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto
05/03/2001WO2001030844A1 Dna encoding human alpha1g-c t-type calcium channel
05/03/2001WO2001030815A1 Redox reversible hcv proteins with native-like conformation
05/03/2001WO2001030801A1 Antisense modulation of integrin-linked kinase expression
05/03/2001WO2001030800A1 Antisense modulation of y-box binding protein 1 expression
05/03/2001WO2001030798A1 Transgenic mice containing trp gene disruptions
05/03/2001WO2001030797A1 Antisense modulation of methionine aminopeptidase 2 expression
05/03/2001WO2001030794A1 Enzymatic substrate, synthesis method and uses
05/03/2001WO2001030757A1 Drug discharge pump inhibitors
05/03/2001WO2001030489A2 Device and method for hybridizing double-stranded dna samples on oligomer arrays
05/03/2001WO2001030395A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression
05/03/2001WO2001030394A1 Treatment of cancer
05/03/2001WO2001018241A8 Improved method for nucleotide detection and devices used therein
05/03/2001WO2001012840A3 Anti-epha2 antibodies as a cancer diagnostic
05/03/2001WO2001001144A3 Hybridization of target dna with immobilized nucleic acid analogs
05/03/2001WO2000078802A3 Secreted polypeptides and corresponding polynucleotides
05/03/2001WO2000077242A3 Detection of microorganisms
05/03/2001WO2000077214A3 Characterization of the yeast transcriptome
05/03/2001WO2000077168A3 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS
05/03/2001WO2000075332A3 USE OF THE REGULATORY SUBUNIT OF THE CAMP DEPENDENT PROTEIN KINASE (PKA) FROM DICTYOSTELIUM FOR cAMP MEASUREMENTS
05/03/2001WO2000073789A3 Method for the prognostic estimation of the risk of the onset of cognitive restrictions by measuring the length of telemers
05/03/2001WO2000073431A3 Methods and compositions for measuring ion channel conductance
05/03/2001WO2000066789A3 Polynucleotide matrix-based method of identifying microorganisms
05/03/2001WO2000065093A3 In situ hybridization methods for reducing the occurrence of false positives and for targeting multiple microorganisms
05/03/2001WO2000057180A8 Use of lna in mass spectrometry
05/03/2001WO2000052201A3 Test system for detecting a splicing reaction and use thereof
05/03/2001US20010000752 Housing having a plurality of capillaries into which fluid flowing through the flow path is divided to flow simultaneously before being recombined, and heating appartus for producing the three temperature phases of PCR
05/03/2001DE19951189A1 Verfahren zur Unterscheidung von 5-Position Methylierungsänderungen von Cytosin-Basen und Cytosin-zu-Thymin Mutationen und zum Nachweis von single nucleotide polymorphisms (SNPs) oder Punktmutation in genomischer DNA Method for distinguishing 5-position methylation changes of cytosine bases and cytosine-to-thymine mutations and for the detection of single nucleotide polymorphisms (SNPs) or point mutation in genomic DNA
05/03/2001DE19950953A1 Rapid quantitative determination of lentiviral vector titers, useful for vectors intended for gene therapy comprises real-time polymerase chain reaction
05/03/2001DE19949179A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid
05/03/2001DE19948087A1 Strukturierter Probenträger und Verfahren zu seiner Herstellung Structured sample support and process for its preparation
05/03/2001CA2407652A1 Device and method for hybridizing double-stranded dna samples on oligomer arrays
05/03/2001CA2389834A1 Genetic sequences associated with neural cell proliferation and disease